A Pharmacokinetic Substudy of the TDE-PH-304 Protocol
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
A sub-study to the TDE-PH-304 protocol to assess the pharmacokinetics of patients
transitioning from a twice daily dosing regimen of oral treprostinil to a three times daily
dosing regimen.